PO:07:096 | Safety of filgotinib in the treatment of rheumatoid arthritis: results from the multicentre SOFIA study
Background. To evaluate safety of filgotinib in terms of frequency, severity, and type of adverse events (AEs) and to identify predictors of AEs in a multicentre cohort of patients with rheumatoid arthritis (RA). Materials and Methods. This is a prospective multicentre study that included pat...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
PAGEPress Publications
2025-11-01
|
| Serija: | Reumatismo |
| Teme: | |
| Online pristup: | https://www.reumatismo.org/reuma/article/view/2136 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|